Embika 100 Mg Injection is a prescription drug, available for use as Injection. Primarily, it is used for the treatment of Urinary Tract Infection. Embika 100 Mg Injection also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Embika 100 Mg Injection. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Embika 100 Mg Injection as well, which are listed below. Such side effects of Embika 100 Mg Injection normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Embika 100 Mg Injection is Severe for pregnant women and Unknown for women who are breastfeeding. In addition, Embika 100 Mg Injection's effects on the liver, heart and kidney are discussed below in the Embika 100 Mg Injection related warnings section.
Embika 100 Mg Injection is contraindicated in people with pre-existing medical conditions like Dehydration, Parkinson's Disease, Hearing Loss as it can result in adverse effects. Other contraindications of Embika 100 Mg Injection have been discussed in the sections ahead.
Drug reaction of Embika 100 Mg Injection with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Embika 100 Mg Injection is safe while driving, and is is addictive in nature.
Embika 100 Mg Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Embika 100 Mg Injection is used -
Moderate
Mild
Unknown
Is the use of Embika 100 Mg Injection safe for pregnant women?
Pregnant women may get severe side effects after taking Embika. If you are pregnant, do not take Embika without a doctor's advice.
Is the use of Embika 100 Mg Injection safe during breastfeeding?
Information about safety of Embika for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Embika 100 Mg Injection on the Kidneys?
Use of Embika may be dangerous for kidney. Do not use it without doctor advice.
What is the effect of Embika 100 Mg Injection on the Liver?
Side effects of Embika rarely affect the liver.
What is the effect of Embika 100 Mg Injection on the Heart?
Side effects of Embika rarely affect the heart.
Embika 100 Mg Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Embika 100 Mg Injection unless your doctor advises you to do so -
Is this Embika 100 Mg Injection habit forming or addictive?
Forming a habit of Embika 100 Mg Injection has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Embika 100 Mg Injection does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Embika 100 Mg Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Embika 100 Mg Injection for mental disorders.
Interaction between Food and Embika 100 Mg Injection
Taking Embika 100 Mg Injection with food does not harm your health.
Interaction between Alcohol and Embika 100 Mg Injection
Information about the interaction of Embika 100 Mg Injection and alcohol is not currently available because this topic has not been researched yet.
Yes, Embika is effective against bacteria (Pseudomonas). But it is also found that Pseudomonas can get resistant to this drug and in that case Embika will not produce desired results. If you are experiencing no symptomatic relief after taking this medicine then inform your doctor and follow his/her instructions.
Yes, Embika is nephrotoxic. Nephrotoxicity depends on dose and duration of therapy. Thus, nephrotoxicity is likely to occur if Embika taken a high dose for a long time or may occur if the drug is given to a patient that already suffer from kidney problem. Nephrotoxicity associated with this drug may reduce or minimize by taking some precaution before consuming this drug like monitor kidney functions regularly and do not take it in high doses. Avoid taking Embika with another nephrotoxic drug. If you notice any urine discoloration after taking this drug then inform your doctor immediately.
Yes, Embika has been reported to cause ototoxicity (hearing loss or deafness) which is irreversible and may progress after discontinuation of the drug. It is a common side effect of this medicine. If you experience hearing loss or deafness after consuming or applying for this medicine, then consult your doctor and follow his/her instructions.
No, Embika does not cause constipation in patients who are taking it. However, if you are experiencing constipation after taking this drug then inform your doctor and take precautionary methods such as eating fibrous foods to avoid constipation.
Embika can be safely taken as prescribed by your doctor. Do not discontinue the medicine suddenly or take it longer than prescribed duration.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137
